Katy Fraisse - Safe Orthopaedics Director of Human Resources

ALSAF Stock  EUR 0.06  0.01  8.93%   

Insider

Katy Fraisse is Director of Human Resources of Safe Orthopaedics SA
Phone33 1 34 21 50 00
Webhttps://www.safeorthopaedics.com

Safe Orthopaedics Management Efficiency

The company has return on total asset (ROA) of (0.2784) % which means that it has lost $0.2784 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (639.4) %, meaning that it generated substantial loss on money invested by shareholders. Safe Orthopaedics' management efficiency ratios could be used to measure how well Safe Orthopaedics manages its routine affairs as well as how well it operates its assets and liabilities.
Safe Orthopaedics SA has accumulated 5.28 M in total debt with debt to equity ratio (D/E) of 4.38, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Safe Orthopaedics has a current ratio of 1.61, which is within standard range for the sector. Debt can assist Safe Orthopaedics until it has trouble settling it off, either with new capital or with free cash flow. So, Safe Orthopaedics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Safe Orthopaedics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Safe to invest in growth at high rates of return. When we think about Safe Orthopaedics' use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 11 records

INSIDER Age

Hugo BrugiereNeovacs SA
N/A
PierremeSpineguard
N/A
Julien TellierAcheter Louer
N/A
FFPM MBABiophytis SA
52
Alexandre CourtouxNeovacs SA
N/A
Philippe RousseauBiophytis SA
52
TeylanBiophytis SA
N/A
Benoit CanolleBiophytis SA
45
Charlene MassonNeovacs SA
N/A
Stphane BetteSpineguard
N/A
Pr ZaguryNeovacs SA
N/A
Safe Orthopaedics SA, a medical technology company, develops and markets sterile implants and single-use instruments for the treatment of spinal fracture pathologies in France and internationally. The company was founded in 2010 and is headquartered in ragny-sur-Oise, France. SAFE ORTHOPAEDICS operates under Medical Instruments Supplies classification in France and is traded on Paris Stock Exchange. It employs 134 people. Safe Orthopaedics SA (ALSAF) is traded on Euronext Paris in France and employs 136 people.

Management Performance

Safe Orthopaedics Leadership Team

Elected by the shareholders, the Safe Orthopaedics' board of directors comprises two types of representatives: Safe Orthopaedics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Safe. The board's role is to monitor Safe Orthopaedics' management team and ensure that shareholders' interests are well served. Safe Orthopaedics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Safe Orthopaedics' outside directors are responsible for providing unbiased perspectives on the board's policies.
Michael DeMane, Independent Director
Philippe Petrou, Independent Director
Philippe Chene, Independent Director
FrancoisHenri Reynaud, Administrative and Financial Director, Director
Dominique Petit, Independent Director
Ismael Nujurally, Independent Director
Philippe Oak, Independent Director
Sven Claes, Director of Marketing
Stephanie Robert, Director of Quality and Reglemantary Affairs
MarieYvonne LandelMeunier, Independent Director
Katy Fraisse, Director of Human Resources
Thomas Droulout, Director, Technical Director
Nikolaus Beyer, Chief Commercial Officer
Adam Ross, Director Marketing
Anne Reiser, Independent Director
Sjors Hermans, Senior Vice President of Sales
Alain Coudray, Independent Chairman of the Board
Jochen Esser, Head Germany
Pierre Dumouchel, Chairman of the Board, Chief Executive Officer, Co-Founder
Nathalie Vazquez, HR Director

Safe Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Safe Orthopaedics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Safe Stock Analysis

When running Safe Orthopaedics' price analysis, check to measure Safe Orthopaedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Safe Orthopaedics is operating at the current time. Most of Safe Orthopaedics' value examination focuses on studying past and present price action to predict the probability of Safe Orthopaedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Safe Orthopaedics' price. Additionally, you may evaluate how the addition of Safe Orthopaedics to your portfolios can decrease your overall portfolio volatility.